Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...

Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...

Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

Ozempic one of the most sought-after drugs across the world for its Type 2 Diabetes and weight loss treatment will be available in India at a starting weekly dose of 025 mg priced at INR 2200 ...

While Ozempic offers proven benefits for blood sugar control, weight management, and cardiovascular protection, its arrival ...

Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

Ozempic, the global blockbuster diabetes and weight-loss drug, is finally in India. Novo Nordisk India launched the hugely ...

CHENNAI: Novo Nordisk has introduced Ozempic, its once-weekly injectable semaglutide, to the Indian market on Friday. Designed as an adjunct to diet and exercis ...